Emergence Global Enterprises Inc. (ELOAF)

[Greensmeans]

At March 31, 2021 and December 31, 2020, the Company had advances of $1,229,328
and $1,179,328, respectively, to CEN Biotech Ukraine, LLC, a related party (see
Note 11). The advances were for the purpose of funding the operations of CEN
Biotech Ukraine, LLC.



Bahige (Bill) Chaaban, our Chief Executive Officer and member of our Board of
Directors, and Usamakh Saadikh, a member of our Board of Directors, each
directly own 25.5% of CEN Ukraine respectively. The remaining 49% of CEN Ukraine
is owned by XN Pharma, which is an entity jointly owned by Bahige (Bill) Chaaban
and Usamakh Saadikh. Bahige (Bill) Chaaban and Usamakh Saadikh do not currently
hold any positions with CEN Ukraine. CEN Ukraine is operated and controlled by
its sole director. Pursuant to Ukrainian law, shareholders of a company do not
have the ability to control the company or the actions of its director. CEN
Ukraine is operated under the direction of its management pursuant to the
guidelines of Ukrainian law. These loans are unsecured, non-interest bearing,
and are due on demand